Results 131 to 140 of about 27,191 (241)

Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene Fusions

Veterinary and Comparative Oncology, Volume 24, Issue 2, Page 393-406, June 2026.
ABSTRACT Spontaneously occurring primary canine pulmonary adenocarcinoma (cPAC) exhibits clinicopathological and molecular similarities to never‐smoker human lung cancers. Shared genomic alterations, including point mutations, indel mutations and copy number changes particularly in HER2 signalling, are significant therapeutic targets, especially for ...
Sharadha Sakthikumar, William P. D. Hendricks, David Rainford, William Selleck, Natalia Briones, Christopher Coggins, Natalie Quan, Victoria Zismann, Gwendolen Lorch, Aleksandar Sekulic, Jeffrey M. Trent   +10 more
wiley   +1 more source

Extensive Myelofibrosis of Bone Marrow

, 2002
extensive myelofibrosis of ...
Lawrence, Christine
core  

Therapy-related myelofibrosis does not appear to exist

, 2017
Key Points There is no evidence to support the existence of therapy-related myelofibrosis. Therapy for previous malignancy has no impact on myelofibrosis prognosis.
Taghi Manshouri, Lucia Masarova, Gabriele Todisco, Jorge E. Cortes, Hagop M. Kantarjian, Srdan Verstovsek, Zeev Estrov, Kate J. Newberry   +7 more
core   +1 more source

Primary myelofibrosis: current therapeutic options

, 2016
Primary myelofibrosis is a Philadelphia-negative myeloproliferative neoplasm characterized by clonal myeloid expansion, followed by progressive fibrous connective tissue deposition in the bone marrow, resulting in bone marrow failure.
Saad, M.J.A
core   +1 more source

Profile of pomalidomide and its potential in the treatment of myelofibrosis

Therapeutics and Clinical Risk Management, 2015
Krisstina L Gowin, Ruben A Mesa Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA Abstract: Myelofibrosis, a Philadelphia-negative myeloproliferative neoplasm, is in a new treatment era after the discovery of ...
Gowin KL, Mesa RA
doaj  

Successful Management of Lupus‐Associated Autoimmune Myelofibrosis with Tofacitinib: A Case Report

ACR Open Rheumatology
We report a case of a 34‐year‐old woman with systemic lupus erythematosus (SLE) who developed thrombocytopenia and was diagnosed with lupus‐associated autoimmune myelofibrosis.
Hamidreza Soltani, Ali Dehghan
doaj   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 study. [PDF]

Oncologist
Kiladjian JJ, Borate U, Abruzzese E, De Stefano V, Gong T, Breccia M, Palandri F, Pane F, Patriarca A, Reikvam H, Rein L, Yacoub A, Zhou F, Stouffs M, Assad A, Vannucchi AM.   +15 more
europepmc   +1 more source